NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Resistell AG

Resistell AG

Private
MuttenzHealthcare & Life Scienceshttps://resistell.com/

Last Round

Grant

Jan 1, 2024

Total Funding Raised

$19.98M

Company Overview

Resistell AG is a medtech company developing a rapid antibiotic susceptibility testing (AST) platform using nanomotion technology to combat antimicrobial resistance.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Biotech Equipment, Precision Medicine, Clinical Trials, Medical AI

Business Model

B2B

Customer Profile

Hardware Sales, Usage-Based SaaS, Government Contracts

AI Layer

Application

Keywords

antibiotic susceptibility testingASTrapid ASTnanomotion technologyphenotypic ASTantimicrobial resistanceAMRsepsis diagnosticssuperbug detectiongrowth-independent diagnosticsmachine learning diagnosticsin vitro diagnosticsbloodstream infection diagnosticsdiagnostic consumableshigh-throughput diagnostics

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Resistell AG Comparables

Compare Resistell AG with similar companies based on industry and business-model similarity.

Resistell AG comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
SoundCell B.V.
92%
PhAST Diagnostics
88%
Biolumo Sp. z o.o.
88%

Resistell AG Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
GrantJan 1, 2024
Series BDec 19, 2022
GrantJul 3, 2020
Series ADec 17, 2019
GrantJul 1, 2019
Seed
Dec 9, 2018

Key People

Founding team and executive leadership

Danuta Cichocka

Co-Founder & CEO

Founding Team

Martin Birk

Fractional CFO

Executive Team

Grzegorz Gonciarz

Chief Operating Officer

Executive Team

Resistell AG Investors

Notable investors and investment history

Resistell AG investors
InvestorRounds
European Innovation Council FundGrant
Launchpad Venture GroupSeries B
TRUMPF VentureSeries B, Series A
Alpana VenturesSeries A
InnosuisseGrant
OCCIDENTSeries B, Series A, Seed
Zurcher KantonalbankSeries B, Series A

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jan 21, 2026

    Monthly visitors increased 142% MoM.

  • Jan 5, 2026

    Monthly visitors increased 125% MoM.

Resistell AG Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Resistell AG Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Resistell AG's valuation, stock price, and market status.

Firmographic Details

HeadquartersMuttenz
Employee Range19
Year Founded2018
Last FundingJan 1, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.